Preventive cardiology| Volume 104, ISSUE 4, P538-542, August 15, 2009

Utility of C-Reactive Protein for Cardiovascular Risk Stratification Across Three Age Groups in Subjects Without Existing Cardiovascular Diseases

      The relative utility of conventional and novel risk factors in predicting cardiovascular disease (CVD) in relation to age remains unclear. We examined the discriminative ability of C-reactive protein (CRP) and Framingham risk score across young (35 to 50 years), middle (51 to 65 years), and older (≥65 years) aged participants from the Scottish Health Surveys (n = 5,944, 44.5% men). CRP data and conventional risk factors were collected at baseline. During an average follow-up of 7.1 years, 308 CVD events (a composite of fatal and nonfatal events incorporating acute myocardial infarction, coronary artery bypass surgery, percutaneous coronary angioplasty, stroke, and heart failure) occurred. The log CRP/SD predicted the risk of CVD events in middle-age (hazard ratio 2.20, 95% confidence interval 1.34 to 3.61) and older (hazard ratio 1.85, 95% confidence interval 1.23 to 2.78) participants, after adjustment for the Framingham risk score. Using receiver operating characteristic (ROC) curves, the area under the curve for the Framingham risk factor model for predicting CVD events was greater in the younger (ROC 0.78) and middle-age (ROC 0.72) participants than in the older participants (ROC 0.59), although the discriminative ability was not substantially improved by adding the CRP data. In conclusion, our results have demonstrated the steadily decreasing predictive value of conventional risk factors with advancing age, although CRP has limited additive value for CVD risk stratification. Our results provide validation of the recently devised Framingham risk factor algorithm for use in primary care in participants <65 years old.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Danesh J.
        • Wheeler J.G.
        • Hirschfield G.M.
        • Eda S.
        • Eiriksdottir G.
        • Rumley A.
        • Lowe G.D.
        • Pepys M.B.
        • Gudnason V.
        C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
        N Engl J Med. 2004; 350: 1387-1397
        • Pearson T.A.
        • Mensah G.A.
        • Alexander R.W.
        • Anderson J.L.
        • Cannon III, R.O.
        • Criqui M.
        • Centers for Disease Control and Prevention; American Heart Association
        Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
        Circulation. 2003; 107: 499-511
        • Wang T.J.
        • Gona P.
        • Larson M.G.
        • Tofler G.H.
        • Levy D.
        • Newton-Cheh C.
        • Jacques P.F.
        • Rifai N.
        • Selhub J.
        • Robins S.J.
        • Benjamin E.J.
        • D'Agostino R.B.
        • Vasan R.S.
        Multiple biomarkers for the prediction of first major cardiovascular events and death.
        N Engl J Med. 2006; 355: 2631-2639
        • Cook N.R.
        • Buring J.E.
        • Ridker P.M.
        The effect of including C-reactive protein in cardiovascular risk prediction models for women.
        Ann Intern Med. 2006; 145: 21-29
        • Olsen M.H.
        • Hansen T.W.
        • Christensen M.K.
        • Gustafsson F.
        • Rasmussen S.
        • Wachtell K.
        • Ibsen H.
        • Torp-Pedersen C.
        • Hildebrandt P.R.
        N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
        Eur Heart J. 2007; 28: 1374-1381
        • Folsom A.R.
        • Chambless L.E.
        • Ballantyne C.M.
        • Coresh J.
        • Heiss G.
        • Wu K.K.
        • Boerwinkle E.
        • Mosley Jr, T.H.
        • Sorlie P.
        • Diao G.
        • Sharrett A.R.
        An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.
        Arch Intern Med. 2006; 166: 1368-1373
        • Sattar N.
        • Murray H.M.
        • McConnachie A.
        • Blauw G.J.
        • Bollen E.L.
        • Buckley B.M.
        • Cobbe S.M.
        • Ford I.
        • Gaw A.
        • Hyland M.
        • Jukema J.W.
        • Kamper A.M.
        • Macfarlane P.W.
        • Murphy M.B.
        • Packard C.J.
        • Perry I.J.
        • Stott D.J.
        • Sweeney B.J.
        • Twomey C.
        • Westendorp R.G.
        • Shepherd J.
        • PROSPER Study Group
        C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
        Circulation. 2007; 115: 981-989
        • de Ruijter W.
        • Westendorp R.G.
        • Assendelft W.J.
        • den Elzen W.P.
        • de Craen A.J.
        • le Cessie S.
        • Gussekloo J.
        Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.
        BMJ. 2009; 338: a3083
        • Zethelius B.
        • Berglund L.
        • Sundström J.
        • Ingelsson E.
        • Basu S.
        • Larsson A.
        • Venge P.
        • Arnlöv J.
        Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
        N Engl J Med. 2008; 358: 2107-2116
        • Kistorp C.
        • Raymond I.
        • Pedersen F.
        • Gustafsson F.
        • Faber J.
        • Hildebrandt P.
        N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
        JAMA. 2005; 293: 1609-1616
        • Kannel W.B.
        Coronary heart disease risk factors in the elderly.
        Am J Geriatr Cardiol. 2002; 11: 101-107
        • Hamer M.
        • Molloy G.J.
        • Stamatakis E.
        Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms.
        J Am Coll Cardiol. 2008; 52: 2156-2162
        • The Scottish Government Statistics
        Scottish Health Survey Publications.
        (Accessed November 2007)
        • Information Services Division, NHS National Services Scotland
        (Accessed February 2008)
        • D'Agostino Sr, R.B.
        • Vasan R.S.
        • Pencina M.J.
        • Wolf P.A.
        • Cobain M.
        • Massaro J.M.
        • Kannel W.B.
        General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
        Circulation. 2008; 117: 743-753
        • Olsen M.H.
        • Hansen T.W.
        • Christensen M.K.
        • Gustafsson F.
        • Rasmussen S.
        • Wachtell K.
        • Ibsen H.
        • Torp-Pedersen C.
        • Hildebrandt P.R.
        Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
        J Hypertens. 2008; 26: 26-34
        • Woodward M.
        • Brindle P.
        • Tunstall-Pedoe H.
        • SIGN group on risk estimation
        Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC).
        Heart. 2007; 93 (2007): 172-176
        • Lawlor D.A.
        • Harbord R.M.
        • Timpson N.J.
        • Lowe G.D.
        • Rumley A.
        • Gaunt T.R.
        • Baker I.
        • Yarnell J.W.
        • Kivimäki M.
        • Kumari M.
        • Norman P.E.
        • Jamrozik K.
        • Hankey G.J.
        • Almeida O.P.
        • Flicker L.
        • Warrington N.
        • Marmot M.G.
        • Ben-Shlomo Y.
        • Palmer L.J.
        • Day I.N.
        • Ebrahim S.
        • Smith G.D.
        The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants.
        PLoS ONE. 2008; 3: e3011
        • Pai J.K.
        • Mukamal K.J.
        • Rexrode K.M.
        • Rimm E.B.
        C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies.
        PLoS ONE. 2008; 3: e1395
        • Khovidhunkit W.
        • Kim M.S.
        • Memon R.A.
        • Shigenaga J.K.
        • Moser A.H.
        • Feingold K.R.
        • Grunfeld C.
        Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.
        J Lipid Res. 2004; 45: 1169-1196
        • Simons L.A.
        • Simons J.
        • Friedlander Y.
        • McCallum J.
        Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years.
        Atherosclerosis. 2001; 159: 201-208